Shield Therapeutics Share Discussion Threads

[peachie 74] 19/3/2020 10:29

Genuinely hasn’t undermined my confidence. The management would not all sit and analyse the protocol for a H2H study surely. Someone is to blame, yes. They missed a small detail that is pretty much irrelevant.

And yes, totally transparent and reported it straight away.

[crankyman] 19/3/2020 10:18

Bigger issue is that it undermines confidence in the management. Flip side is that they are extremely transparent. This would all wash away with a good deal and moving this to being a cash cow.

[peachie 74] 19/3/2020 10:03

The “ good “ news is from my point of view, is fundamentally nothing has changed here. The RNS the other day is such a small detail. Total over reaction. Even if the whole H2H had been shown to be invalid ( which it really wasn’t) the reaction was extreme.
The drug is still proven to be a suitable alternative to IV. FACT.
The US deal is still to come. And is totally unrelated to the recent storm in a tea cup.
This product is still in prime position to become a massive part of the multi billion dollar Fe deficiency industry.
DYOR
Good luck.
Will we look back and laugh that we could buy these at 55p ?!

[peachie 74] 18/3/2020 15:09

Are these big buys or sells or both. Hard to tell with the tight spread

[peachie 74] 18/3/2020 15:08

What are the questions best1467 ?

[daveboy1] 18/3/2020 14:35

Nice one - much appreciated.

[best1467] 18/3/2020 14:24

I have spoken to the company and have been promised a callback have two specific questions regarding H2H will post when I get the call back or email response

[crankyman] 18/3/2020 14:04

Pound fall will help a little. Figures should be steady growth plus an update on pricing

[best1467] 18/3/2020 13:51

Well we definitely get increased figures what we need is confirmation that the growth is accelerating quarter on quarter in the areas where it’s been available for the last 12 months.

[daveboy1] 18/3/2020 13:17

Can't make much sense of anything at the moment. Too foggy with this panic induced market. Does anyone think the results on March 26 will be positive and help the cause ? I'm hoping for some increased figures from Norgine over the previous year.
Last four companies I've waited for results to come through and they've been pummeled ! Hoping to break the trend lol.
Final thought, be nice to see Carl and other directors steam in again if it's the bargain it appears...

[peachie 74] 18/3/2020 13:06

What a buying opportunity really ..

But I was saying that at 130!

In some respects this is so cheap it puts you off !!!!

[marie1980_m] 18/3/2020 12:09

> Marie

Hope you have still got your SNG.....

— Nobby, still holding with now almost 15% profit. That was a cracking tip.

[crankyman] 18/3/2020 12:06

It’s should have been ITT or PP not ITT AND PP. but yes, storm in a tea cup. Stupid but it’s sentiment.

[peachie 74] 18/3/2020 11:21

Basically if they had set out the pre defined success criteria for the H2H study correctly ( ie They were using the “per protocol “ population for the primary efficacy analysis, not both PP and ITT ) non of this would have happened !!!
As stated the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use actually ADVISE CAUTION IN THE USE OF ITT ANALYSIS. So it’s inclusion in the pre defined success criteria wasn’t even necessary !!!

What a storm in a tea cup !!!!!!!

[nobbygnome] 18/3/2020 07:22

>> Marie

Hope you have still got your SNG.....

[peachie 74] 18/3/2020 07:19

Hard times for a lot of people on these threads Marie, have some consideration and shut up , unless you have some thing constructive to add.

Personally hoping yesterday was ticking a regulatory box with a not to important piece of information. Probably good to get it out before the really good news flow comes, ie US deal.
Hospital beds now at a premium.
IV requires hospitalisation and resus teams etc.
Shield could actually benefit from this horrible situation.

Good luck all. DYOR.

[marie1980_m] 18/3/2020 04:26

Ny Boy best shorter ever ;)

[marie1980_m] 17/3/2020 23:23

I’m still angry on member like Ny Boy who doesn’t have any conscience.

I was short on this share right from 190 but I get opportunity to meet my boy I would like to give him big hug.

I think he is the best shorter ever

[marie1980_m] 17/3/2020 23:10

I genuinely hate member like NY boy Who kept on ramping here.


I think we need to aware to our community that member like my boy is just scam.

Pure scam

Having said that I’m delighted and also sad with this price

[marie1980_m] 17/3/2020 22:54

Nobby,

Needless to say, you lost your presence here as well.

You and Ny boy, both just ramper

[marie1980_m] 17/3/2020 22:53

Hopefully if no fund selling, maybe a over reaction based on current market volatility, let’s see what happens and await news, press, broker comments etc.

Existing vols are quite low


—- As I said earlier, you’re a scam member.
Just scam guy.
I want you to ban from this forum.
Just pure scum lol.


I’m happy Shield come to the ground

[peachie 74] 17/3/2020 20:48

Just another observation.....

The RNS today states the clarity of the results were incorrect in stating non inferiority AT 12 WEEKS for both PP and ITT analyses. ( it was just the more reliable PP group )

But the comparison was extended out to show responders in the FM ( oral ferric maltol ) outperformed the IV FCM group at weeks 24,36 and 52 weeks.
Thus the RNS 22 Oct 2019 where results of the full 52 week AEGIS-H2H still stand largely and today really is very very minor indeed !?

[peachie 74] 17/3/2020 18:14

Yes but as people who know about these things have stated, it’s just worded differently. Not a total waste of time

[best1467] 17/3/2020 17:07

That is true ref Nordgine but Nordgine payed 1 million euro on the release of the H2H study readout it may have been more haven’t looked back